As of 2024-09-15, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (1,612.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.72 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -16691.7%.
The range of the Relative Valuation is (2,101.22) - (1,155.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 57.1x - 64.3x | 60.7x |
| Forward P/E multiples | 22.5x - 31.4x | 27.0x |
| Fair Price | (2,101.22) - (1,155.49) | (1,612.72) |
| Upside | -21717.5% - -11987.7% | -16691.7% |
| Date | P/E |
| 2024-09-13 | -0.26 |
| 2024-09-12 | -0.22 |
| 2024-09-11 | -0.23 |
| 2024-09-10 | -0.23 |
| 2024-09-09 | -0.24 |
| 2024-09-06 | -0.26 |
| 2024-09-05 | -0.27 |
| 2024-09-04 | -0.25 |
| 2024-09-03 | -0.19 |
| 2024-08-30 | -0.21 |
| 2024-08-29 | -0.19 |
| 2024-08-28 | -0.19 |
| 2024-08-27 | -0.19 |
| 2024-08-26 | -0.19 |
| 2024-08-23 | -0.19 |
| 2024-08-22 | -0.19 |
| 2024-08-21 | -0.20 |
| 2024-08-20 | -0.20 |
| 2024-08-19 | -0.20 |
| 2024-08-16 | -0.19 |
| 2024-08-15 | -0.19 |
| 2024-08-14 | -0.21 |
| 2024-08-13 | -0.22 |
| 2024-08-12 | -0.21 |
| 2024-08-09 | -0.21 |
| 2024-08-08 | -0.21 |
| 2024-08-07 | -0.20 |
| 2024-08-06 | -0.22 |
| 2024-08-05 | -0.22 |
| 2024-08-02 | -0.25 |
| 2024-08-01 | -0.28 |
| 2024-07-31 | -0.27 |
| 2024-07-30 | -0.26 |
| 2024-07-29 | -0.28 |
| 2024-07-26 | -0.28 |
| 2024-07-25 | -0.27 |
| 2024-07-24 | -0.27 |
| 2024-07-23 | -0.28 |
| 2024-07-22 | -0.28 |
| 2024-07-19 | -0.30 |
| 2024-07-18 | -0.29 |
| 2024-07-17 | -0.33 |
| 2024-07-16 | -0.33 |
| 2024-07-15 | -0.30 |
| 2024-07-12 | -0.28 |
| 2024-07-11 | -0.28 |
| 2024-07-10 | -0.25 |
| 2024-07-09 | -0.22 |
| 2024-07-08 | -0.22 |
| 2024-07-05 | -0.23 |